the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer
Condition(s):Non-small Cell Lung Cancer; Brain MetastasesLast Updated:July 27, 2021Unknown status